Improved prognostication of renal cell carcinoma using an integrated staging system.
By A. Zisman, A. Pantuck, F. Dorey, J. Said, O. Shvarts, D. Quintana, B. Gitlitz, J. Dekernion, R. Figlin, A. Belldegrun. Journal of Clinical Oncology, 2001
725 citations recorded by the source corpus.
Subfields: Epidemiology, Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/e6d1d913382f93e6066f2959a04c62ef5914cc13
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Pulmonary and Respiratory Medicine
In Surgery
Citations in the corpus
- Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. (2006, background): “Currently, TNM stage, nuclear grade, and patient performance status represent the most commonly used clinical predictors of outcome for patients with RCC (19).”
- EAU guidelines on renal cell carcinoma: 2014 update. (2010, neutral): “A commonly usedmodel is the UISS integrated staging system using TNM stage, Eastern Cooperative Oncology Group PS, and nuclear grade [46,77].”
- Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. (2003, background): “Traditionally, stage, grade, and performance status have been the most useful predictors of outcome for RCC (28).”
- Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma (2003, background): “Recently, Zisman et al.(18) reported a single system for patients with and without metastatic RCC.”
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. (2019, methodology): “The most recent modifications of the stage, size, grade and necrosis (SSIGN) score [18] (Table 3) and the University of California Los Angeles Integrated Staging System (UISS) (Table 4) [19] score are frequently used.”